Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 25.58 billion as of June 27, 2025. Its market cap has decreased by -16.87% in one year.

Market Cap

25.58B

Enterprise Value

24.33B

Revenue

43.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

151.50

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 25.58B, an increase of 495.49%. That is a compound annual growth rate of 19.63%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	25.41B	-39.83%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	195.43B
PharmaEssentia	183.96B
Bora Pharmaceuticals Co., LTD.	83.99B
Lotus Pharmaceutical	57.85B
Oneness Biotech	31.37B
Polaris Group	30.28B
Center Laboratories	27.17B
TaiMed Biologics	25.13B

Market Cap Rankings